中文 | English
Return
Total: 21 , 1/3
Show Home Prev Next End page: GO
Author:(L X ZHU)

2.Efficacy of neoadjuvant therapy on HER2-positive breast cancer: a clinicopathological analysis.

P ZHU ; H LYU ; Q M BAI ; R H SHUI ; X L XU ; W T YANG

Chinese Journal of Pathology 2023;52(9):907-911

4.Clinicopathological features of adult Wilms tumor with BRAF V600E mutation.

H L GAN ; Q F WANG ; X L ZHU ; H LYU ; J WANG

Chinese Journal of Pathology 2023;52(12):1210-1215

5.Application and evaluation of artificial intelligence TPS-assisted cytologic screening system in urine exfoliative cytology.

L ZHU ; M L JIN ; S R HE ; H M XU ; J W HUANG ; L F KONG ; D H LI ; J X HU ; X Y WANG ; Y W JIN ; H HE ; X Y WANG ; Y Y SONG ; X Q WANG ; Z M YANG ; A X HU

Chinese Journal of Pathology 2023;52(12):1223-1229

6.Efficacy of polyetheretherketone rod hybrid surgery in preventing proximal junctional failure after adult spinal deformity surgery.

Y ZHAO ; B Y XU ; L T QI ; L YUE ; R L ZHU ; Z R YU ; X D YI ; C D LI

Chinese Journal of Surgery 2023;61(8):656-665

7.A medium- and long-term comparative observation on volumetric changes of cervical disc herniation after symmetrically or asymmetrically decompression and conservative treatment for cervical spondylotic myelopathy.

A D ZHU ; C L ZHANG ; X YAN ; S FU ; D Z LI ; C DONG ; Y K WANG

Chinese Journal of Surgery 2023;61(8):666-674

9.Effect of comprehensive intervention on hypertension control program in workplaces in China.

Y SHEN ; X WANG ; Z W WANG ; Z CHEN ; M L ZHU ; C CHANG ; R L GAO

Chinese Journal of Epidemiology 2019;40(2):212-217

10.Assessment on the capacity for prevention and control programs for chronic non-communicable diseases in China, in 2014.

X SI ; Y ZHAI ; X L ZHU ; J X MA

Chinese Journal of Epidemiology 2019;40(2):231-236

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 21 , 1/3 Show Home Prev Next End page: GO